Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration
暂无分享,去创建一个
E Reichel | J G Fujimoto | H. Ishikawa | J. Duker | J. Fujimoto | J. Schuman | T. Ko | A. Chan | E. Reichel | A. Witkin | J S Duker | J S Schuman | H Ishikawa | C. Pieroni | A. Chan | C G Pieroni | A J Witkin | T H Ko | A Chan | C. G. Pieroni
[1] M. Trese,et al. Transretinal Pigment Migration: An Optical Coherence Tomographic Study , 2004 .
[2] Angelika Unterhuber,et al. Ultrahigh resolution optical coherence tomography of the monkey fovea. Identification of retinal sublayers by correlation with semithin histology sections. , 2004, Experimental eye research.
[3] B. Hawkins,et al. Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration. , 1991, Archives of ophthalmology.
[4] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[6] J. Fujimoto,et al. In vivo retinal imaging by optical coherence tomography. , 1993, Optics letters.
[7] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[8] Irene Barbazetto,et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.
[9] A. Ho. Effect of Lesion Size, Visual Acuity, and Lesion Composition on Visual Acuity Change With and Without Verteporfin Therapy for Choroidal Neovascularization Secondary To Age-Related Macular Degeneration: TAP and VIP Report No. 1 , 2004 .
[10] Michael Stur,et al. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. , 2003, American journal of ophthalmology.
[11] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[12] D. Zacks,et al. Transretinal pigment migration: an optical coherence tomographic study. , 2004, Archives of ophthalmology.
[13] E. Gragoudas,et al. Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.
[14] N. Bressler,et al. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6. , 2004, Archives of ophthalmology.
[15] J. Duker,et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.
[16] J. Duker,et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular hole pathology and repair. , 2004, Ophthalmology.
[17] W. Amoaku,et al. Treatment of Age-Related Macular Degeneration , 2004, Journal of the Royal Society of Medicine.
[18] Mauricio E Pons,et al. Redefining the limit of the outer retina in optical coherence tomography scans. , 2005, Ophthalmology.
[19] I Lavery,et al. Safe use of lasers. , 1978, Occupational health; a journal for occupational health nurses.
[20] G. Ripandelli,et al. Optical coherence tomography. , 1998, Seminars in ophthalmology.
[21] J. Fujimoto,et al. Ultrahigh-resolution ophthalmic optical coherence tomography , 2001, Nature Medicine.
[22] J. Fujimoto,et al. Optical coherence tomography of the human retina. , 1995, Archives of ophthalmology.
[23] W R Green,et al. Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.
[24] J. Fujimoto,et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. , 2003, Archives of ophthalmology.
[25] A Hofman,et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.
[26] J. Català Mora,et al. Photodynamic Therapy Of Subfoveal Choroidal Neovascularization With Verteporfin. Fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report nº2 , 2003 .
[27] S. Sarks. New vessel formation beneath the retinal pigment epithelium in senile eyes. , 1973, The British journal of ophthalmology.
[28] M. Killingsworth,et al. Evolution of soft drusen in age-related macular degeneration , 1994, Eye.
[29] N. Bressler,et al. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.
[30] M. Blumenkranz,et al. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. , 2002, Archives of ophthalmology.
[31] N. Bressler,et al. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.